Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · IEX Real-Time Price · USD

56.41

+0.50 (0.89%)

At close: Jul 19, 2024, 4:00 PM

56.42

+0.01 (0.02%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $6.47 billion as of July 22, 2024. Its market cap has increased by 101.09% in one year.

Market Cap

6.47B

Enterprise Value

6.60B

1-Year Change

101.09%

Ranking

#1108

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $6.47B, an increase of 1,442.54%. That is a compound annual growth rate of 14.48%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	5.91B	-27.75%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Repligen	6.92B
Halozyme Therapeutics	6.88B
Jazz Pharmaceuticals	6.87B
Tempus AI	6.82B
Exelixis	6.58B
HealthEquity	6.38B
Grifols	6.30B
Elanco Animal Health	6.29B

Market Cap Rankings